Mitochondrial Trans-2-Enoyl-CoA Reductase (MECR) (C-Term) Peptide
MECR
Reactivité: Humain
Hôte: Synthetic
BP, WB
-
- Antigène Tous les produits MECR
- MECR (Mitochondrial Trans-2-Enoyl-CoA Reductase (MECR))
- Protein Region
- C-Term
- Origine
- Humain
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Séquence
- RRPEMKNFFK DMPQPRLALN CVGGKSSTEL LRQLARGGTM VTYGGMAKQP
- Attributs du produit
- This is a synthetic peptide designed for use in combination with anti-MECR Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Indications d'application
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Conseil sur la manipulation
- Avoid repeated freeze-thaw cycles.
- Stock
- -20 °C
- Stockage commentaire
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Antigène
- MECR (Mitochondrial Trans-2-Enoyl-CoA Reductase (MECR))
- Synonymes
- CGI-63 Peptide, FASN2B Peptide, NRBF1 Peptide, AI195831 Peptide, Nrbf1 Peptide, mitochondrial trans-2-enoyl-CoA reductase Peptide, MECR Peptide, Mecr Peptide
- Sujet
-
MECR catalyzes the reduction of trans-2-enoyl-CoA to acyl-CoA with chain length from C6 to C16 in an NADPH-dependent manner with preference to medium chain length substrate. It may have a role in the mitochondrial synthesis of fatty acids.
Alias Symbols: CGI-63, FASN2B, NRBF1
Protein Interaction Partner: HNF4A,PPARA,RARA,RXRA,THRB,Hnf4a,PPARA,Ppara,RARA,Rxra,Thrb
Protein Size: 297 - Poids moléculaire
- 32 kDa
- ID gène
- 51102
- NCBI Accession
- NM_001024732, NP_001019903
-
Vous êtes ici:
